Anizatrectinib
Anizatrectinib (hTrkA-IN-1) is an orally active and blood-brain barrier-penetrant TrkA kinase/hERG channel inhibitor. Anizatrectinib can be used for research on TrkA-mediated related diseases, such as pain, cancer, inflammation, and inflammatory diseases.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 1824664-89-2
- Fòrmula: C29H32FN7O2
- Peso molecular:529.61
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Actividad biológica
Descripciòn
IC50 & Target
[1]|
TrkA |
In Vitro
Anizatrectinib (Compound 1) has decreased inhibitory activity against the hERG channel (IC50 = 20 μM)[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Parmacokinetics
| Species | Dose | Route | AUC | Cmax |
|---|---|---|---|---|
| Rat[1] | 10 mg/kg mg/kg | p.o. | 2.57 μg·h/mL | 1.06 μg/mL |
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
No. CAS 1824664-89-2
-
Peso molecular 529.61
-
Fòrmula C29H32FN7O2
-
SMILES
O=C(NC1=C(C)C(C2=CN=C(C)N=C2)=NN1C3=CC=CC=C3)N[C@@H]4CN(CCOC)C[C@H]4C5=CC=CC(F)=C5
-
Synonyms
hTrkA-IN-1
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)